The Hypothalamic-Pituitary-adrenal (HPA) Axis Study is an ancillary study of the Childhood Asthma Management Program, which is designed to determine the long-term effects of 3 treatments (two classes of anti-inflammatory agents [budesonide or nedocromil] and placebo) over 5-6 1/2 years. All children will receive (as needed) short-acting beta agonist. The effects of the medications on the HPA axis will be tested in the ancillary study over the duration of the study.
Showing the most recent 10 out of 497 publications